SMITHS FALLS, ON, Sept. 13, 2017 /CNW/ - Canopy Growth
Corporation (TSX:WEED) ("Canopy Growth" or the "Company") is
pleased to announce that it has entered into a supply agreement
with AusCann Group Holdings Ltd. ("AusCann"), whereby Canopy Growth
will act as AusCann's exclusive supplier of medical cannabis for
the Australian market, beginning with the transfer of a range of
medicines for research and commercialization in Australia.
The Australian market continues to present attractive growth
opportunities for medical cannabis and through the Company's
minority ownership stake and excellent working relationship with
AusCann, it is in a prime position to realize this potential for
its shareholders.
"This agreement is a positive step in enabling Australian
patients to have access to high quality cannabinoid medications,"
said Elaine Darby, Managing Director, AusCann. "I'm excited to
move forward with this partnership, and continue to utilize the
production scale of existing partners to accelerate our own sales
function and market presence."
As an emerging market, the size of this initial shipment is not
expected to affect registered customer's ability to purchase
product through Tweedmainstreet.com where consistent product
availability has stabilized thanks to strong production from the
Canopy-wide production platform.
This agreement, which continues to allow Canopy Growth to pursue
other Australian opportunities, follows a recent announcement
issued September 11, 2017, in which the Company
announced a strategic partnership with Alcaliber S.A.
("Alcaliber"), a leading pharmaceutical producer that
last year exported 125 tonnes of alkaloids to 40 countries
around the world, representing a 20% market share for Narcotic Raw
Material (NRM).
Whether Europe, South America, Australia, or at home, Canopy Growth is
working hard to bring its recognized, high quality genetics to the
world.
Here's to Future Growth Down Under.
About Canopy Growth Corporation
Canopy Growth is a world-leading diversified cannabis company,
offering distinct brands and curated cannabis varieties in dried,
oil and capsule forms. Through its wholly‑owned subsidiaries,
Canopy Growth operates numerous state-of-the-art production
facilities with over half a million square feet of GMP-certified
indoor and greenhouse production capacity, all to an unparalleled
level of quality assurance procedures and testing. Canopy Growth
has established partnerships with leading sector names in
Canada and abroad, with interests
and operations spanning four continents. The Company is proudly
dedicated to educating healthcare practitioners, providing
consistent access to high quality cannabis products, conducting
robust clinical research, and furthering the public's understanding
of cannabis. For more information visit www.canopygrowth.com.
Notice Regarding Forward Looking Statements
This news release contains forward-looking statements. Often, but
not always, forward-looking statements can be identified by the use
of words such as "plans", "expects" or "does not expect", "is
expected", "estimates", "intends", "anticipates" or "does not
anticipate", or "believes", or variations of such words and phrases
or state that certain actions, events or results "may", "could",
"would", "might" or "will" be taken, occur or be achieved.
Forward-looking statements involve known and unknown risks,
uncertainties and other factors which may cause the actual results,
performance or achievements of Canopy Growth Corporation, Tweed
Inc., Tweed Farms Inc., Mettrum Health Corp., or Bedrocan Canada
Inc. to be materially different from any future results,
performance or achievements expressed or implied by the
forward-looking statements. Examples of such statements include
future operational and production capacity, the impact of enhanced
infrastructure and production capabilities, and forecasted
available product selection. The forward-looking statements
included in this news release are made as of the date of this news
release and Canopy Growth Corp. does not undertake an obligation to
publicly update such forward-looking statements to reflect new
information, subsequent events or otherwise unless required by
applicable securities legislation.
Neither the TSX Exchange nor its Regulation Services Provider
(as that term is defined in policies of the TSX Exchange) accepts
responsibility for the adequacy or accuracy of this release.
SOURCE Canopy Growth Corporation